Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth

NCT02251483 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Diarrhea Predominant Irritable Bowel Syndrome
Small Intestinal Bacterial Overgrowth

Interventions

OTHER: Serum-derived bovine immunoglobulin protein isolate (SBI)
OTHER: Placebo

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]